Loading clinical trials...
Loading clinical trials...
Phase I Study of Itacitinib in Combination With Tocilizumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease
Conditions
Interventions
Itacitinib
Tocilizumab
Locations
2
United States
Columbia University Irving Medical Center
New York, New York, United States
Weill Cornell Medical College - New York Presbyterian Hospital
New York, New York, United States
Start Date
January 20, 2020
Primary Completion Date
December 13, 2021
Completion Date
December 13, 2021
Last Updated
June 4, 2024
NCT00106925
NCT06450925
NCT04337515
NCT06681922
NCT03369353
NCT03842696
Lead Sponsor
Columbia University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions